Nov 7, 2007
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell...
“We are committed to working with Gamida Cell and look forward to the potential of providing an improved treatment option for patients with hematological cancers.”
Marjie Hadad, 972-54-536-5220 or Teva Pharmaceutical Industries Ltd. Dan Suesskind, 972-2-941-1717 Chief Financial Officer or Teva Pharmaceutical Industries Ltd. via PR-inside.com
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Teva Announces Launch of Generic Protonix Table... (from Jan '08) | 4 hr | Stewart | 21 |
| Teva Announces Tentative Approval of Generic Pr... (from Jan '08) | Aug 15 | Larry | 7 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | Aug 14 | Rebecca | 1090 |
| Study shows Teva's laquinimod slows MS | Jun '08 | WEL | 1 |
| Teva Announces Launch Of Generic Wellbutrin XL(... | Jun '08 | jmb | 1 |
| FDA says generic Wellbutrin OK despite reports | Apr '08 | Greg | 1 |
| Drug Side Effects, Fatalities Are Increasing in... | Apr '08 | ben | 2 |

